Cargando...
Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future
Nephrotoxicity from cancer therapies is common and increasingly encountered in clinical practice, such that the subfield of “onco-nephrology” has emerged. Conventional chemotherapeutic drugs and novel agents targeting specific genes/proteins are effective cancer therapies but suffer from a number of...
Gardado en:
| Publicado en: | J Am Soc Nephrol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society of Nephrology
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6065079/ https://ncbi.nlm.nih.gov/pubmed/29959196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2018050488 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|